These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33531083)

  • 1. De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning.
    Santana MVS; Silva-Jr FP
    BMC Chem; 2021 Feb; 15(1):8. PubMed ID: 33531083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method.
    Zhang H; Liang B; Sang X; An J; Huang Z
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention Mechanism-Based Graph Neural Network Model for Effective Activity Prediction of SARS-CoV-2 Main Protease Inhibitors: Application to Drug Repurposing as Potential COVID-19 Therapy.
    Wu Y; Li K; Li M; Pu X; Guo Y
    J Chem Inf Model; 2023 Nov; 63(22):7011-7031. PubMed ID: 37960886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Bung N; Krishnan SR; Bulusu G; Roy A
    Future Med Chem; 2021 Mar; 13(6):575-585. PubMed ID: 33590764
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M
    Hossain A; Rahman ME; Rahman MS; Nasirujjaman K; Matin MN; Faruqe MO; Rabbee MF
    Comput Biol Med; 2023 May; 157():106785. PubMed ID: 36931201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors.
    Ghosh K; Amin SA; Gayen S; Jha T
    J Mol Struct; 2021 Jan; 1224():129026. PubMed ID: 32834115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
    Kundu D; Selvaraj C; Singh SK; Dubey VK
    J Biomol Struct Dyn; 2021 Jun; 39(9):3428-3434. PubMed ID: 32362243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M
    Hicks EG; Kandel SE; Lampe JN
    Bioorg Med Chem Lett; 2022 Jun; 66():128732. PubMed ID: 35427739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach.
    Augustin TL; Hajbabaie R; Harper MT; Rahman T
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease.
    Andrianov AM; Shuldau MA; Furs KV; Yushkevich AM; Tuzikov AV
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations.
    Arshia AH; Shadravan S; Solhjoo A; Sakhteman A; Sami A
    Comput Biol Med; 2021 Dec; 139():104967. PubMed ID: 34739968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
    Mohammad T; Shamsi A; Anwar S; Umair M; Hussain A; Rehman MT; AlAjmi MF; Islam A; Hassan MI
    Virus Res; 2020 Oct; 288():198102. PubMed ID: 32717346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment.
    Liu J; Xu L; Guo W; Li Z; Khan MKH; Ge W; Patterson TA; Hong H
    Exp Biol Med (Maywood); 2023 Nov; 248(21):1927-1936. PubMed ID: 37997891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series.
    Miglani V; Sharma P; Kumar Narula A
    Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37612857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Molecular Generative Model of COVID-19 Main Protease Inhibitors Using Long Short-Term Memory-Based Recurrent Neural Network.
    Mehrzadi A; Rezaee E; Gharaghani S; Fakhar Z; Mirhosseini SM
    J Comput Biol; 2024 Jan; 31(1):83-98. PubMed ID: 38054946
    [No Abstract]   [Full Text] [Related]  

  • 18. Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2.
    Yassine R; Makrem M; Farhat F
    Biomed Res Int; 2021; 2021():6696012. PubMed ID: 34124259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.
    Andrianov AM; Kornoushenko YV; Karpenko AD; Bosko IP; Tuzikov AV
    J Biomol Struct Dyn; 2021 Sep; 39(15):5779-5791. PubMed ID: 32662333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.